REGISTER

FR
Search
×
FR

Placeholder headline

This is just a placeholder headline

API TR 2583 : Measurement of Produced Water for Custody Transfer

$

174

BUY NOW

Placeholder headline

This is just a placeholder headline

API TR 2581: Wet Gas Sampling

$

189

BUY NOW

Placeholder headline

This is just a placeholder headline

API TR 2581 Wet Gas Sampling : Errata 1

$

0

BUY NOW

Placeholder headline

This is just a placeholder headline

API 510: Pressure Vessel Inspection Code: In-service Inspection, Rating, Repair, and Alteration

$

481

BUY NOW

Placeholder headline

This is just a placeholder headline

API SPEC 6AV1: Validation of Safety and Shutdown Valves for Sandy Service : Edition 4

$

208

BUY NOW

Placeholder headline

This is just a placeholder headline

API 510: Errata 2

$

0

BUY NOW

Placeholder headline

This is just a placeholder headline

API SPEC 16B Coiled Tubing, Snubbing and Wireline Well Intervention Equipment

$

189

BUY NOW

Placeholder headline

This is just a placeholder headline

API SPEC 5CT: Casing and Tubing w/ Addendum 1

$

518

BUY NOW

Placeholder headline

This is just a placeholder headline

API SPEC 5CT: Casing and Tubing Addendum 1

$

0

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 1161: Hazardous Liquid Pipeline Operator Qualification (OQ) : Edition 6

$

301

BUY NOW

ISO 17822:2020

ISO 17822:2020 In vitro diagnostic test systems – Nucleic acid amplification-based examination procedures for detection and identification of microbial pathogens – Laboratory quality practice guide

CDN $312.00

SKU: c56685d4e56c Categories: ,

Description

This document describes the particular clinical laboratory practice requirements to ensure the quality of detection, identification and quantification of microbial pathogens using nucleic acid amplification tests (NAAT).

It is intended for use by laboratories that develop, and/or implement and use, or perform NAAT for medical, research or health-related purposes. This document does not apply to the development of in vitro diagnostic (IVD) medical devices by manufacturers. However, it does include verification and validation of such devices and/or the corresponding processes when implemented and used by the laboratories.

Edition

1

Published Date

2020-12-01

Status

PUBLISHED

Pages

39

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

This document describes the particular clinical laboratory practice requirements to ensure the quality of detection, identification and quantification of microbial pathogens using nucleic acid amplification tests (NAAT).

It is intended for use by laboratories that develop, and/or implement and use, or perform NAAT for medical, research or health-related purposes. This document does not apply to the development of in vitro diagnostic (IVD) medical devices by manufacturers. However, it does include verification and validation of such devices and/or the corresponding processes when implemented and used by the laboratories.

Previous Editions

Can’t find what you are looking for?

Please contact us at: